David Hollenback
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Lipid metabolism and biosynthesis 5
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Jack W. Singer (8 shared papers)Lynn Bonham (8 shared papers)Thayer White (4 shared papers)David G. Breckenridge (6 shared papers)Archana Vijayakumar (3 shared papers)Jamie Bates (5 shared papers)Anna Zagórska (3 shared papers)Robert Brockett (4 shared papers)
- Journals
- Journal of Hepatology (6 papers)Clinical Cancer Research (2 papers)Expert Opinion on Therapeutic Targets (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Investigative Medicine (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
David Hollenback
20 papers receiving 477 citations
Peers
Comparison fields: 5 of 51
- Biochemistry 99
- Hepatology 73
- Cancer Research 56
- Epidemiology 110
- Hematology 31
Countries citing papers authored by David Hollenback
This map shows the geographic impact of David Hollenback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hollenback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hollenback more than expected).
Fields of papers citing papers by David Hollenback
This network shows the impact of papers produced by David Hollenback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hollenback. The network helps show where David Hollenback may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hollenback, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 183 | |
| 2 | 2005 | 50 | |
| 3 | Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. | 2003 | 49 |
| 4 | 2003 | 39 | |
| 5 | 2014 | 35 | |
| 6 | 2005 | 30 | |
| 7 | 2006 | 23 | |
| 8 | 2006 | 18 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 11 | |
| 11 | 2005 | 9 | |
| 12 | 2008 | 9 | |
| 13 | 2024 | 4 | |
| 14 | 2017 | 3 | |
| 15 | 1998 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2003 | 1 | |
| 20 | 2005 | 1 |
About David Hollenback
David Hollenback is a scholar working on Biochemistry, Epidemiology, Hepatology, Cancer Research and Molecular Biology, having authored 21 papers that have together received 491 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Sphingolipid Metabolism and Signaling (6 papers), Lipid metabolism and biosynthesis (5 papers), Cancer, Lipids, and Metabolism (3 papers), Liver physiology and pathology (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Biochemistry (99 citations), Hepatology (73 citations), Cancer Research (56 citations), Epidemiology (110 citations) and Hematology (31 citations). David Hollenback has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Jack W. Singer, Lynn Bonham, Thayer White, David G. Breckenridge, Archana Vijayakumar, Jamie Bates, Anna Zagórska, Robert Brockett, Saritha Kusam and Michael E. Coon. Their work appears in journals such as Journal of Hepatology, Clinical Cancer Research, Expert Opinion on Therapeutic Targets, Journal of Pharmacology and Experimental Therapeutics and Journal of Investigative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.